Rankings
▼
Calendar
RLAY (Relay Therapeutics, Inc.) Stock Financials & Earnings | Market Cap Arena
RLAY
Relay Therapeutics, Inc.
Mkt Cap
$2B
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$15M
Net Income (TTM)
-$276M
EPS (TTM)
-$1.62
Free Cash Flow (TTM)
-$236M
Gross Margin
91.2%
Op. Margin
-1971.5%
Net Margin
-1800.5%
FCF Margin
-1536.0%
P/S Ratio (TTM)
124.5x
P/E Ratio (TTM)
—
YoY Rev Growth
+53.5%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$226K
-$83M
-$101M
Q2 23
$119K
-$88M
-$106M
Q3 23
$25M
-$56M
-$74M
Q4 23
-$1K
-$1K
-$92M
Q1 24
$10M
$10M
-$90M
Q2 24
$0
$0
-$101M
Q3 24
$0
$0
-$96M
Q4 24
$0
$0
-$85M
Q1 25
$8M
$8M
-$85M
Q2 25
$677K
$677K
-$77M
Q3 25
$0
-$748K
-$80M
Q4 25
$7M
$6M
-$61M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
1609.7x
—
Q2 23
2030.1x
—
Q3 23
74.1x
—
Q4 23
74.9x
—
Q1 24
54.1x
—
Q2 24
54.3x
—
Q3 24
191.1x
—
Q4 24
191.1x
—
Q1 25
249.0x
—
Q2 25
228.9x
—
Q3 25
228.9x
—
Q4 25
124.5x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$67M
-$69M
Q2 23
-$69M
-$70M
Q3 23
-$75M
-$76M
Q4 23
-$89M
-$89M
Q1 24
-$50M
-$52M
Q2 24
-$66M
-$66M
Q3 24
-$75M
-$75M
Q4 24
-$58M
-$58M
Q1 25
-$73M
-$74M
Q2 25
-$55M
-$55M
Q3 25
-$62M
-$62M
Q4 25
-$45M
-$45M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$2M
Q2 23
$2M
Q3 23
$590K
Q4 23
$118K
Q1 24
$2M
Q2 24
$11K
Q3 24
$227K
Q4 24
$0
Q1 25
$384K
Q2 25
$26K
Q3 25
$1K
Q4 25
$1K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
-46.1%
+60.6%
Q2 23
-67.4%
+35.8%
Q3 23
+7226.2%
+14.5%
Q4 23
-100.4%
+26.1%
Q1 24
+4327.9%
-1.0%
Q2 24
-100.0%
-5.1%
Q3 24
-100.0%
-2.4%
Q4 24
+100.0%
-7.8%
Q1 25
-23.3%
-7.8%
Q2 25
—
-23.1%
Q3 25
—
-16.6%
Q4 25
—
-20.4%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$22M
9521.2%
Q2 23
$23M
19673.1%
Q3 23
$22M
86.6%
Q4 23
$19M
—
Q1 24
$27M
271.7%
Q2 24
$27M
—
Q3 24
$22M
—
Q4 24
$18M
—
Q1 25
$19M
251.7%
Q2 25
$15M
2141.8%
Q3 25
$16M
—
Q4 25
$13M
186.7%
marketcaparena.com
OpEx Breakdown
R&D
G&A
SG&A
Quarter
R&D
G&A
SG&A
Q1 23
$83M
$20M
—
Q2 23
$88M
$20M
—
Q3 23
$81M
$18M
—
Q4 23
$77M
$17M
—
Q1 24
$82M
$20M
—
Q2 24
$92M
$20M
—
Q3 24
$77M
$20M
—
Q4 24
$68M
$17M
—
Q1 25
$74M
$19M
—
Q2 25
$64M
$14M
—
Q3 25
$68M
—
$11M
Q4 25
$55M
$13M
—
marketcaparena.com
Revenue Segments
Operating Segments
Quarter
Operating Segments
Q2 25
$677K
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$161M
$777M
$938M
Q2 23
$146M
$726M
$872M
Q3 23
$151M
$659M
$811M
Q4 23
$144M
$606M
$750M
Q1 24
$153M
$597M
$750M
Q2 24
$134M
$554M
$688M
Q3 24
$152M
$687M
$840M
Q4 24
$124M
$657M
$781M
Q1 25
$94M
$617M
$710M
Q2 25
$114M
$543M
$657M
Q3 25
$92M
$505M
$596M
Q4 25
$84M
$0
$84M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
121M
+0.3%
Q2 23
122M
+0.3%
Q3 23
122M
+0.5%
Q4 23
123M
+0.3%
Q1 24
131M
+6.7%
Q2 24
133M
+1.5%
Q3 24
140M
+5.6%
Q4 24
167M
+19.3%
Q1 25
169M
+1.1%
Q2 25
171M
+1.2%
Q3 25
172M
+0.7%
Q4 25
172M
-0.5%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 18
—
—
FY 19
—
—
FY 20
$520K
159
FY 21
$12K
245
FY 22
$4K
327
FY 23
$79K
323
FY 24
$38K
261
FY 25
$90
170K
marketcaparena.com